Bill Information > SB 5020
Search for another bill or initiative:
SB 5020 - 2021-22
Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.
Bill Status-at-a-Glance
See Bill History for complete details on the bill
As of Tuesday, March 2, 2021 06:35 PM
Current Version:
Substitute - SSB 5020
Current Status:
SWays & Means
Where is it in the process?
IntroducedIn CommitteeOn FloorCalendarPassedChamberIn the Senate:In the House:
After Passage:Passed LegislatureOn Governor'sDeskGovernor ActedSession Law

Bill Status-at-a-Glance

As of Tuesday, March 2, 2021 06:35 PM
See Bill History for complete details on the bill
Current Version:
Substitute - SSB 5020
Current Status:
SWays & Means
Where is it in the process?
IntroducedIn CommitteeOn FloorCalendarPassedChamber
Senate:
House:
Passed LegislatureOn Governor'sDeskGovernor ActedSession Law
AfterPassage:
Bill History

2021 REGULAR SESSION

Dec 17
Prefiled for introduction.
Jan 11
First reading, referred to Health & Long Term Care. (View Original Bill)
Jan 22
Public hearing in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee Materials)
Feb 12
Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee Materials)
HLTC - Majority; 1st substitute bill be substituted, do pass. (View 1st Substitute) (Majority Report)
Minority; do not pass. (Minority Report)
Minority; without recommendation. (Minority Report)
And refer to Ways & Means.
Feb 15
Referred to Ways & Means.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos